A pharmaceutical firm conducts a research to judge the connection between size of time taking drug X and dimension of tumor. They enlist 2400 sufferers with the identical kind of benign tumor who’ve been on drug X for various lengths of time (measured in days). They discover that the longer the affected person is on the drug, the smaller the patientâs tumor dimension (measured in quantity). Actually, they report the outcomes as r(2398) = -.21, with significance of p < .0001. What's your preliminary notion of this info? What are different methods, past wanting on the p-value alone, you may use to attempt to interpret what this final result of r(2398) = -.21 tells us in regards to the relationship between size of time taking drug X and the scale of the tumor? Help your responses.